RSI News
As necessary and sparingly, RSI publishes short news items that demonstrate the range of work in which our team is engaged. Only when relevant and permissible do we mention the actual client, otherwise we simply refer to the type of client.
RSI is pleased to announce that Norman Shippee recently joined the team as a Climate and Applications Specialist. Dr. Shippee earned his PhD at the University of Victoria. He is an experienced researcher who has focused on establishing stakeholder-defined storm metrics to facilitate safe operations in the marine transportation field.…
The Society for Risk Analysis (SRA) Council has awarded Dr. Hartnett the 2016 Chauncey Starr Distinguished Young Risk Analyst Award. The Chauncey Starr Distinguished Young Risk Analyst Award is awarded to any SRA member age 40 years or younger for outstanding achievement in science or public policy relating to risk…
Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult use of psychiatric drugs using publicly available, nationally representative data. These analyses demonstrate that 1 of 6 US adults reported taking psychiatric drugs at least…
RSI launched the Climate Change Hazards Information Portal (CCHIP).
Following up on the recommendations put forth by the Expert Management Panel on River Flood Mitigation, the Environmental and Safety Management (ESM) and Water Resources (WS) business units of the City of Calgary are currently assessing how to best develop a suite of watershed-scale climate models to capture various weather event…
This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant…
Developing a suite of watershed-scale climate models.
This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant…